Mechlorethamine.

Nitrogen mustards form a reactive aziridinium ion that glutathione S-transferases attach directly to glutathione. Higher cellular glutathione lowers the amount of intact alkylating agent left to react.

NAC supplies cysteine, the rate limiting substrate for glutathione synthesis, and its own free thiol also reacts with electrophiles. Both routes reduce the pool of unreacted alkylating agent.

Free sulfhydryl groups react readily with the aziridinium intermediate formed by nitrogen mustards. Cysteine therefore attaches to the agent before it reaches other nucleophiles.

DNA alkylation activates poly-ADP-ribose polymerase, which consumes NAD+ as its substrate, so heavy alkylation drains the cellular NAD pool and constrains the energy and signalling reactions that depend on it. The cited work examined NAD as a factor in cellular stress responses to alkylating agents, with mechlorethamine named within that class. This was measured in cultured cells and is a mechanism observation, not a human outcome.

NR is phosphorylated to nicotinamide mononucleotide and then adenylylated to NAD+, feeding the pool that PARP consumes after alkylation damage. Whether raising that pool is desirable during cytotoxic exposure is an open clinical question and cuts both ways, since DNA repair capacity is the thing being modulated. The precursor chemistry is settled; the consequence is not.

NMN sits one step from NAD+ in the salvage pathway and raises the pool PARP draws on during alkylation-induced repair. As with other NAD precursors, supporting repair capacity during deliberate cytotoxic exposure is a clinical decision with arguments in both directions. Read this as pathway biochemistry rather than a recommendation.

Nicotinamide feeds NAD synthesis through the salvage route and also inhibits PARP activity directly at higher concentrations, so it acts on both sides of the same reaction. Those two actions point in opposite directions with respect to DNA repair after alkylation. That ambiguity is the reason to name the interaction rather than to characterise it as helpful.

Glutathione is the tripeptide of glutamate, cysteine and glycine, and glycine availability contributes to its synthesis alongside the usually rate-limiting cysteine. Glutathione is the principal cellular nucleophile that scavenges alkylating intermediates. The relationship is settled biochemistry and applies to alkylating chemistry generally.

Glutamine is deamidated to glutamate, which condenses with cysteine in the first and rate-setting step of glutathione synthesis. Cellular glutathione status determines how much of an electrophilic intermediate is conjugated before it reaches DNA. This is textbook thiol biochemistry.

Dihydrolipoic acid, the reduced form, regenerates oxidised glutathione and other thiols, keeping the nucleophilic pool in its reactive state. That pool is what reacts with electrophilic alkylating species. The recycling chemistry is established; the clinical consequence during cytotoxic exposure is a prescriber's question.

Both glutathione peroxidase and thioredoxin reductase are selenoenzymes, and together they maintain the reduced state of the cell's thiol systems. Alkylating chemistry both consumes thiols and generates oxidative stress. Selenium status is a background determinant of that capacity rather than an interacting agent.

PARP-1 and several nucleotide-excision repair proteins carry zinc-finger domains that require coordinated zinc to recognise damaged DNA. Alkylation damage is handled by exactly those systems. Zinc status is permissive for repair and does not interact with the alkylating chemistry itself.

Thymidylate synthase requires a folate-derived one-carbon unit to build dTMP, and excision repair after DNA damage consumes deoxynucleotides to fill the resected gap. Folate status therefore constrains repair throughput. The relationship is standard one-carbon biochemistry.

Without B12, methylfolate cannot be demethylated back into the pool that supplies nucleotide synthesis, and the folate becomes functionally trapped. Any folate-dependent repair capacity is therefore B12-dependent as well. Textbook one-carbon biochemistry, independent of the alkylating agent.

Alkylating exposure generates lipid peroxidation, and alpha-tocopherol terminates the propagating radical chain within the membrane before being recycled by ascorbate. This addresses a downstream consequence rather than the alkylation step itself. Whether antioxidant support alongside cytotoxic therapy is desirable is a prescriber's decision, not a formulation one.

Ascorbate reduces the tocopheroxyl radical back to alpha-tocopherol at the aqueous side of the membrane, which is why the two are described as a couple. The relevance here is to oxidative consequences downstream of alkylation, not to the alkylation chemistry. High-dose ascorbate has its own pro-oxidant behaviour at pharmacological concentrations, which complicates the picture.

Taurine is the end product of cysteine catabolism and acts as an osmolyte and a scavenger of hypochlorous acid rather than as a nucleophile toward alkylating agents. Its sulfonic acid group is not nucleophilic in the way a thiol is, so it does not substitute for glutathione. The row exists to mark the distinction, which is often blurred in formulation copy.

Melatonin scavenges radicals directly and its oxidation products remain active as scavengers, a cascade property distinct from vitamin E or C. This addresses oxidative sequelae rather than DNA alkylation. As with all antioxidant pairings alongside cytotoxic agents, direction of benefit is a clinical question and not settled.